Literature DB >> 25769526

Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.

Michael Osthoff1, Sarah L McGuinness2, Aaron Z Wagen2, Damon P Eisen3.   

Abstract

OBJECTIVES: Extended-spectrum beta-lactamase-expressing Gram-negative bacilli (ESBL-GNB) now commonly cause community-acquired infections, including urinary tract infections (UTI), and represent a challenge for practitioners in choosing empirical antibiotics. The aim of this study was to describe the epidemiology and clinical characteristics of UTIs/bacteriuria due to ESBL-GNB in Australia.
METHODS: At a single-site tertiary referral hospital, 100 cases with UTIs/bacteriuria due to ESBL-GNB were matched to 100 cases where UTIs/bacteriuria were caused by organisms matching the ESBL bacterial species that had routine susceptibility to antibiotics. Potential risk factors for ESBL-GNB UTI/bacteriuria and differences in clinical outcomes were identified.
RESULTS: Length of admission prior to positive sample (odds ratio (OR) 1.3, p = 0.03, per week), exposure to antibiotics (OR 5.7, p < 0.001), return from overseas travel (OR 6.5, p = 0.002), and nursing home residency (OR 4.2, p = 0.03) were identified as risk factors associated with ESBL-GNB UTI/bacteriuria in the multivariate analysis. In addition, ESBL-GNB-infected cases subsequently had a longer inpatient stay (median 6 vs. 2 days, p = 0.002) and were admitted to the intensive care unit more frequently (28/100 vs. 8/100, p < 0.001).
CONCLUSIONS: Our results emphasize the need for culture of a mid-stream urine specimen prior to commencing antibacterials, especially in patients with the risk factors identified herein associated with ESBL-GNB UTI/bacteriuria.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; ESBL; Gram-negative bacteria; Urinary tract infection

Mesh:

Substances:

Year:  2015        PMID: 25769526     DOI: 10.1016/j.ijid.2015.03.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  17 in total

Review 1.  Travel and the Spread of Drug-Resistant Bacteria.

Authors:  Kevin L Schwartz; Shaun K Morris
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

2.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.

Authors:  Liam Toner; Nathan Papa; Sani H Aliyu; Harveer Dev; Nathan Lawrentschuk; Samih Al-Hayek
Journal:  World J Urol       Date:  2015-10-28       Impact factor: 4.226

3.  Simultaneous gut colonisation and infection by ESBL-producing Escherichia coli in hospitalised patients.

Authors:  Johny Asir; Shashikala Nair; Sheela Devi; Kenchappa Prashanth; Rajagopalan Saranathan; Reba Kanungo
Journal:  Australas Med J       Date:  2015-06-30

4.  Bacteremia in Early Infancy: Etiology and Management.

Authors:  Joseph B Cantey; Amanda C Farris; Sarah M McCormick
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

5.  Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States.

Authors:  Vimalanand S Prabhu; Joseph S Solomkin; Goran Medic; Jason Foo; Rebekah H Borse; Teresa Kauf; Benjamin Miller; Shuvayu S Sen; Anirban Basu
Journal:  Antimicrob Resist Infect Control       Date:  2017-10-27       Impact factor: 4.887

Review 6.  Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.

Authors:  Paul-Louis Woerther; Antoine Andremont; Anu Kantele
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

Review 7.  The magnitude of extended-spectrum beta-lactamase- producing Enterobacteriaceae from clinical samples in Ethiopia: a systematic review and meta-analysis.

Authors:  Kuma Diriba; Ephrem Awulachew; Aschelew Gemede; Asrat Anja
Journal:  Access Microbiol       Date:  2021-01-28

8.  Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).

Authors:  Marion Opatowski; Christian Brun-Buisson; Mehdi Touat; Jérôme Salomon; Didier Guillemot; Philippe Tuppin; Laurence Watier
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

9.  Results after implementation of a protocol on the incidence of urinary tract infection in an intensive care unit.

Authors:  Anna Letícia Miranda; Ana Lúcia Lyrio de Oliveira; Daiana Terra Nacer; Cynthia Adalgisa Mesojedovas Aguiar
Journal:  Rev Lat Am Enfermagem       Date:  2016-09-09

Review 10.  Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review.

Authors:  Justin Tenney; Nicholas Hudson; Hazar Alnifaidy; Justin Ting Cheung Li; Kathy Harriet Fung
Journal:  Saudi Pharm J       Date:  2018-02-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.